Literature DB >> 16001283

Neoplastic fever: all who shiver are not infected.

Kenneth V I Rolston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16001283     DOI: 10.1007/s00520-005-0863-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  7 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Current spectrum of bacterial infections in patients with cancer.

Authors:  D Yadegarynia; J Tarrand; I Raad; K Rolston
Journal:  Clin Infect Dis       Date:  2003-10-15       Impact factor: 9.079

3.  Oral antipyretic therapy evaluation of the propionic acid derivatives ibuprofen, ketoprofen, fenoprofen and naproxen.

Authors:  S Keinänen-Kiukaanniemi; S Similä; K Kouvalainen
Journal:  Padiatr Padol       Date:  1980

4.  How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test.

Authors:  J C Chang
Journal:  Heart Lung       Date:  1987-03       Impact factor: 2.210

5.  Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.

Authors:  I Chatzinikolaou; D Abi-Said; G P Bodey; K V Rolston; J J Tarrand; G Samonis
Journal:  Arch Intern Med       Date:  2000-02-28

6.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

Review 7.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.